GENE Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020	FY-2019	FY-2018	FY-2017	FY-2016	FY-2015	FY-2014
Period Ended	06/30/2023	06/30/2022	06/30/2021	06/30/2020	06/30/2019	06/30/2018	06/30/2017	06/30/2016	06/30/2015	06/30/2014
Operating Revenue	$8.69 M	$6.79 M	$120,554.00	$9,864.00	$25,444.00	$189,254.00	$518,506.00	$824,586.00	$2.01 M	$4.56 M
Cost of Revenue	$4.34 M	$321,223.00	$361,027.00	$251,511.00	$276,267.00	$300,088.00	$492,417.00	$743,060.00	$891,243.00	$1.84 M
Gross Profit	$4.35 M	$6.47 M	-$240,473.00	-$241,647.00	-$250,823.00	-$110,834.00	$26,089.00	$81,526.00	$1.12 M	$2.73 M
Gross Profit Ratio	0.5	0.95	-1.99	-24.5	-9.86	-0.59	0.05	0.1	0.56	0.6
Research and Development Expenses	$1.28 M	$705,507.00	$3.11 M	$2.48 M	$2.36 M	$2.21 M	$2.37 M	$2.58 M	$2.85 M	$3.30 M
General & Administrative Expenses	$9.01 M	$2.18 M	$4.16 M	$4.06 M	$3.83 M	$3.02 M	$2.93 M	$3.53 M	$4.66 M	$4.25 M
Selling & Marketing Expenses	$2.71 M	$1.89 M	$1.12 M	$637,295.00	$576,077.00	$1.07 M	$2.72 M	$3.19 M	$4.50 M	$6.25 M
Selling, General & Administrative Expenses	$11.72 M	$4.07 M	$5.28 M	$4.70 M	$4.41 M	$4.08 M	$5.66 M	$6.72 M	$9.16 M	$10.50 M
Other Expenses	-$1.76 M	-$1.66 M	-$1.39 M	-$1.14 M	-$856,707.00	-$426,258.00	-$253,159.00	$58,002.00	$564,821.00	-$610,107.00
Operating Expenses	$12.30 M	$3.11 M	$7.00 M	$6.03 M	$5.91 M	$5.87 M	$8.02 M	$8.64 M	$10.88 M	$12.58 M
Cost And Expenses	$16.64 M	$3.43 M	$7.36 M	$6.28 M	$6.19 M	$6.17 M	$8.51 M	$9.39 M	$11.77 M	$14.42 M
Interest Income	$220,161.00	$36,256.00	$62,394.00	$22,507.00	$25,794.00	$15,218.00	$38,765.00	$67,100.00	$39,951.00	$116,047.00
Interest Expense	$29,515.00	$15,215.00	$14,049.00	$14,823.00	$20,031.00	$28,843.00	$31,995.00	$28,889.00	$264,694.00	$744,199.00
Depreciation & Amortization	$676,583.00	$578,668.00	$478,222.00	$265,933.00	$156,248.00	$303,749.00	$371,611.00	$390,074.00	$232,203.00	$338,445.00
EBITDA	-$9.24 M	-$3.71 M	-$7.06 M	-$6.08 M	-$6.00 M	-$5.96 M	-$7.59 M	-$8.44 M	-$9.15 M	-$10.71 M
EBITDA Ratio	-1.06	-0.55	-58.59	-616.8	-235.74	-31.5	-14.63	-10.23	-4.55	-2.35
Operating Income	-$9.92 M	-$4.29 M	-$7.06 M	-$6.08 M	-$6.00 M	-$5.98 M	-$8.00 M	-$8.46 M	-$8.10 M	-$9.33 M
Operating Income Ratio	-1.14	-0.63	-58.59	-616.8	-235.74	-31.58	-15.42	-10.26	-4.03	-2.05
Total Other Income/Expenses Net	-$3.72 M	-$2.87 M	-$14,049.00	-$14,823.00	-$427,513.00	$527,049.00	-$415,218.00	$65,134.00	$1.17 M	$346,935.00
Income Before Tax	-$11.91 M	-$7.16 M	-$7.08 M	-$6.10 M	-$6.43 M	-$5.46 M	-$8.40 M	-$8.46 M	-$8.81 M	-$10.13 M
Income Before Tax Ratio	-1.37	-1.05	-58.71	-618.3	-252.54	-28.87	-16.21	-10.26	-4.38	-2.22
Income Tax Expense	-$158,329.00	-$32,125.00	$130,320.00	$205,146.00	$407,482.00	$542,267.00	$31,995.00	-$303,183.00	$597,312.00	-$576,307.00
Net Income	-$11.75 M	-$7.13 M	-$7.21 M	-$6.30 M	-$6.83 M	-$5.46 M	-$8.40 M	-$8.46 M	-$8.81 M	-$10.13 M
Net Income Ratio	-1.35	-1.05	-59.79	-639.1	-268.55	-28.87	-16.21	-10.26	-4.38	-2.22
EPS	-0.12	-0.0773	-0.0844	-0.15	-0.24	-1.35	-2.22	-2.76	-4.6	-9.87
EPS Diluted	-0.12	-0.0773	-0.0844	-0.15	-0.24	-1.35	-2.22	-2.76	-4.6	-9.87
Weighted Average Shares Out	$101.38 M	$92.20 M	$85.44 M	$41.55 M	$28.24 M	$4.06 M	$3.79 M	$3.06 M	$1.92 M	$1.03 M
Weighted Average Shares Out Diluted	$101.38 M	$92.20 M	$85.44 M	$41.55 M	$28.24 M	$4.06 M	$3.79 M	$3.06 M	$1.92 M	$1.03 M
Link

Genetic Technologies Limited (GENE) Financials

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification